Insulet sees US Appeals Court overturn lower court injunction against Eoflow
MLex Summary: Insulet and Eoflow have seen the US Court of Appeals for the Federal Circuit reverse a preliminary injunction that barred Eoflow from manufacturing and marketing its EOPatch insulin delivery...To view the full article, register now.
Already a subscriber? Click here to view full article